Skip to content

Balchem Corporation Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 23, 2026 results vs estimates

Balchem Corporation · E.BCPC.NASDAQ · United States
Use symbol E.BCPC.NASDAQ in our API & Excel add-in to retrieve this data ↓
170.40
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 50%
Bubble Risk LOW
Realised Volatility (20D) 21.84%

Balchem Corporation Forecast

Balchem Corporation short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is positive (6 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 21.8% a year, a typical one-standard-deviation range is 165.16–175.64 over a week, 159.66–181.14 over a month and 133.19–207.61 over a year. (Signals as of 1 Nov 2026.)

Balchem Corporation Price Chart

MacroFinance.ai

Balchem Corporation Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Balchem Corporation
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Balchem Corporation
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Balchem Corporation
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Balchem Corporation
P/E
31.95x
Cheap vs own history
QoQ −10.1%
YoY −6.2%
now 31.947130.66 low39.63 high
ⓘP/E As of 22 Nov 2026.See Balchem Corporation returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Balchem Corporation
P/S
4.92x
Mid-range vs own history
QoQ −8.6%
YoY −1.9%
now 4.92194.72 low5.83 high
ⓘP/S As of 22 Nov 2026.See Balchem Corporation returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Balchem Corporation
P/B
4.11x
Mid-range vs own history
QoQ −8.3%
YoY +5.0%
now 4.11393.79 low4.66 high
ⓘP/B As of 22 Nov 2026.See Balchem Corporation returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Balchem Corporation
EV/EBITDA
20.12x
Cheap vs own history
QoQ −9.2%
YoY −3.4%
now 20.122719.32 low24.16 high
ⓘEV/EBITDA As of 22 Nov 2026.See Balchem Corporation returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Balchem Corporation
EV/Sales
4.99x
Mid-range vs own history
QoQ −8.9%
YoY −2.6%
now 4.99064.79 low5.94 high
ⓘEV/Sales As of 22 Nov 2026.See Balchem Corporation returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Balchem Corporation
FCF Yield
3.2%
Strong vs own history
QoQ +8.3%
YoY −0.1%
now 3.17552.73 low3.48 high
ⓘFCF Yield As of 22 Nov 2026.See Balchem Corporation returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Balchem Corporation
Earnings Yield
3.1%
Strong vs own history
QoQ +11.3%
YoY +6.7%
now 3.13022.52 low3.26 high
ⓘEarnings Yield As of 22 Nov 2026.See Balchem Corporation returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Balchem Corporation
Dividend Yield
0.6%
Mid-range vs own history
QoQ +7.0%
YoY +1.4%
now 0.5640.48 low0.61 high
ⓘDividend Yield As of 22 Nov 2026.See Balchem Corporation returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Balchem Corporation
Market Cap
$5.5B
Mid-range vs own history
QoQ −6.6%
YoY +7.4%
now 5458.25284,922 low5,913 high
ⓘMarket Cap As of 22 Nov 2026.See Balchem Corporation returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Balchem Corporation
Net Debt
$76M
Low vs own history
QoQ −26.4%
YoY −28.7%
now 76.1876.18 low111.84 high
ⓘNet Debt As of 22 Nov 2026.See Balchem Corporation returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Balchem Corporation
Net Debt / EBITDA
0.28x
Low vs own history
QoQ −28.2%
YoY −35.4%
now 0.2770.28 low0.43 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Balchem Corporation returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Balchem Corporation
Current Ratio
2.47x
Mid-range vs own history
QoQ −7.4%
YoY −9.3%
now 2.4672.07 low2.72 high
ⓘCurrent Ratio As of 22 Nov 2026.See Balchem Corporation returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Balchem Corporation
Quick Ratio
1.39x
Weak vs own history
QoQ −10.8%
YoY −17.0%
now 1.38851.33 low1.67 high
ⓘQuick Ratio As of 22 Nov 2026.See Balchem Corporation returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Balchem Corporation
Interest Coverage
26.13x
Mid-range vs own history
QoQ +7.5%
YoY +38.9%
now 26.133718.82 low26.13 high
ⓘInterest Coverage As of 22 Nov 2026.See Balchem Corporation returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Balchem Corporation
Debt / Equity
0.11x
Low vs own history
QoQ −16.1%
YoY −19.0%
now 0.10740.11 low0.14 high
ⓘDebt / Equity As of 22 Nov 2026.See Balchem Corporation returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Balchem Corporation
Piotroski F-Score
8
Mid-range vs own history
QoQ −11.1%
YoY 0.0%
now 88 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Balchem Corporation returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Balchem Corporation
Altman Z-Score
10.98
Strong vs own history
QoQ −3.4%
YoY +4.5%
now 10.98019.42 low11.88 high
ⓘAltman Z-Score As of 22 Nov 2026.See Balchem Corporation returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Balchem Corporation, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Balchem Corporation fundamentals: income statement, balance sheet & cash flow

Balchem Corporation reported revenue of $1.04bn and net income of $154.8m in FY2025, the year ended 31 December 2025 — revenue up 8.8% and net income up 20.5% on the prior year. Free cash flow was $173.1m. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$1.04bn
+8.8%
Net income
$154.8m
+20.5%
Gross margin
35.74%
Free cash flow
$173.1m
+18.3%
Net debt
$106.1m
Shares short (30 Oct 2026)
0.50m
1.50 days to cover
Balchem Corporation income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue1,037.2953.7922.4942.4799.0
Cost of revenue666.5617.5620.4661.9555.8
Gross profit370.6336.2302.1280.5243.2
Research & development18.516.815.012.213.5
Selling, general & admin.—136.5127.8123.1102.1
Operating income218.3182.9159.2145.2127.5
EBITDA254.9231.0214.8195.9176.6
Interest expense10.216.522.610.32.5
Pre-tax income199.0166.5137.3133.7125.2
Income tax44.238.028.728.429.1
Net income154.8128.5108.5105.496.1

Download Balchem Corporation fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.BCPC.NASDAQ&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Balchem Corporation

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Balchem Corporation Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLB (Materials sector), the closest tradable exposure to Balchem Corporation; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLB →

Statistical Distribution of Returns

Plus

How Balchem Corporation’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Balchem Corporation behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Balchem Corporation (United States)

Balchem Corporation is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Balchem Corporation?
Balchem Corporation is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Balchem Corporation price?
The latest close is 170.4 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Balchem Corporation in an uptrend?
As of 1 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (6 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Balchem Corporation?
20-day realised volatility is 21.8% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 6.3% over a month and 3.1% over a week.
What factors affect Balchem Corporation?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Balchem Corporation, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Balchem Corporation?
58 backtested tactical asset allocation strategies trade Balchem Corporation through SPY, XLB; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Balchem Corporation returns analysed?
The Statistical Distribution of Returns section shows the distribution of Balchem Corporation daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Balchem Corporation historical data?
In the Free historical data section of this page: the last 10 years of Balchem Corporation daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Balchem Corporation historical data (last 10 years)

Browse or instantly download the last 10 years of Balchem Corporation daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BCPC.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20163.54
2026-11-19165.54
2026-11-18168.73
2026-11-17169.63
2026-11-16171.48
2026-11-13173.14
2026-11-12172.35
2026-11-11173.3
2026-11-10173.54
2026-11-09175.99
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.